Polyoxyethylene Lauryl Ether (Brij-35) and Poloxamer 407–Based Non-ionic Surfactant Vesicles for Dissolution Enhancement of Tacrolimus.

MLA

Hanif, Razia, et al. “Polyoxyethylene Lauryl Ether (Brij-35) and Poloxamer 407–Based Non-Ionic Surfactant Vesicles for Dissolution Enhancement of Tacrolimus.” Journal of Pharmaceutical Innovation, vol. 18, no. 3, Sept. 2023, pp. 1487–99. EBSCOhost, https://doi.org/10.1007/s12247-023-09737-2.

APA

Hanif, R., Khan, M. I., Madni, A., Akhtar, M. F., Sohail, M. F., Saleem, A., Rehman, M., Usmani, S. J., Khan, A., & Masood, A. (2023). Polyoxyethylene Lauryl Ether (Brij-35) and Poloxamer 407–Based Non-ionic Surfactant Vesicles for Dissolution Enhancement of Tacrolimus. Journal of Pharmaceutical Innovation, 18(3), 1487–1499. https://doi.org/10.1007/s12247-023-09737-2

Chicago

Hanif, Razia, Muhammad Imran Khan, Asadullah Madni, Muhammad Furqan Akhtar, Muhammad Farhan Sohail, Ammara Saleem, Mubashar Rehman, Sufyan Junaid Usmani, Aslam Khan, and Athar Masood. 2023. “Polyoxyethylene Lauryl Ether (Brij-35) and Poloxamer 407–Based Non-Ionic Surfactant Vesicles for Dissolution Enhancement of Tacrolimus.” Journal of Pharmaceutical Innovation 18 (3): 1487–99. doi:10.1007/s12247-023-09737-2.